Less Ads, More Data, More Tools Register for FREE

Pin to quick picksETX.L Share News (ETX)

  • There is currently no data for ETX

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Woodford Raises GBP500 Million From Flurry Of London Share Sales (ALLISS)

Mon, 10th Jun 2019 13:33

LONDON (Alliance News) - Over the past week, fund manager Neil Woodford's Woodford Investment Management has conducted a fire sale of its stakes in 20 London-listed companies - raising in excess of GBP500 million - after taking the decision to suspend withdrawals from his equity income fund.

Woodford Investment manages three funds: LF Woodford Income Focus Fund, LF Woodford Equity Income Fund and London-listed Woodford Patient Capital Trust.

LF Woodford Equity Income Fund on Monday last week said the suspension was due to "an increased level of redemptions", with the fund now needing time to "reposition" its portfolio invested in unquoted and less liquid stocks into more liquid investments.

Neil Woodford appeared in a video suggesting his firm faced having to hold a fire sale in order to meet the demand for redemptions from his flagship Woodford Equity Income Fund, which was reported to have hit GBP10 million a day. The stock market guru insisted that his firm, Woodford Investment Management, has a strategy in place to stabilise the fund so holders would eventually be able to access their investments.

According to stock market filings, since Monday last week, Woodford Investment Management has reduced its holdings in the following London listings, in order of the minimum approximate gross value of each disposal:

- vehicle marketplace BCA Marketplace PLC, to 7.14% from 12.59%, GBP78.7 million;

- subprime lender Provident Financial PLC, to 18.43% from 23.44%, GBP65.7 million;

- housebuilder Countryside Properties PLC, to 10.20% from 15.00%, GBP65.1 million;

- guarantor loan company Amigo Holdings PLC, to 5.57% from 10.03%, GBP57.3 million;

- housebuilder Crest Nicholson Holdings PLC, to 10.01% from 15.08%, GBP48.0 million;

- property investor NewRiver REIT PLC, to 14.9% from 22.3% across three days, GBP46.3 million;

- intellectual property commercialisation company IP Group PLC to 14.08% from 19.00%, GBP40.7 million;

- online estate agent Purplebricks Group PLC, to 19.25% from 28.88% across three days, GBP31 million;

- retailer Card Factory PLC to below 5% from 8.94%, GBP26.1 million; at the end of May, this stake already had been lowered from 10.06%;

- construction firm Watkin Jones PLC, to below 5% from 9.19%, GBP22.2 million;

- construction materials firm Breedon Group PLC to below 5% from 6.83%, GBP21.4 million;

- media firm Time Out Group PLC to below 5% from 16.06%, GBP13.2 million;

- outsourcer and construction firm Kier Group PLC, to 15.87% from 20.01%, GBP10.3 million;

- intellectual property commercialisation company Allied Minds, to 23.22% from 28.21%, GBP9.4 million;

- ten-pin bowling site operator Ten Entertainment Group PLC to 5.54% from 10.08%, GBP6.5 million;

- housebuilder Barratt Developments PLC, to below 5% from 5.07%, GBP4.0 million;

- housebuilder Taylor Wimpey PLC, to below 5% from 5.07%, GBP3.9 million;

- respiratory disease-focused pharma firm Circassia Pharmaceuticals PLC to 24.47% from 28.03%, GBP2.5 million;

- housebuilder Redrow PLC, to below 5% from 5.07%, GBP1.4 million;

- defence firm Babcock International PLC, to below 5% from 5.03%, GBP721,809; and

- drug discovery company e-Therapeutics PLC to 14.11% from 17.89%, GBP193,196.

In total, these sales will have raised proceeds of around GBP550 million for Woodford Investment Management.

More News
29 Oct 2019 18:49

Invesco's Holding In e-Therapeutics Drops To Zero From 32%

Invesco's Holding In e-Therapeutics Drops To Zero From 32%

Read more
7 Oct 2019 09:14

e-therapeutics Loss Narrows On Lower Costs, Collaboration Income

e-therapeutics Loss Narrows On Lower Costs, Collaboration Income

Read more
7 Oct 2019 09:13

e-therapeutics Loss Narrows On Lower Costs, New Collaboration Income

e-therapeutics Loss Narrows On Lower Costs, New Collaboration Income

Read more
13 Aug 2019 12:16

e-Therapeutics Partners With Pharma Firm For Drug Discovery

(Alliance News) - e-Therapeutics PLC on Tuesday said it has agreed to work with an undisclosed global pharmaceutical company, on a project in a specific area of biology, associated with occurs is

Read more
5 Mar 2019 11:50

e-Therapeutics Annual Loss Narrows Amid Reduced Research Costs

LONDON (Alliance News) - e-Therapeutics PLC on Tuesday said its annual loss narrowed as research and development costs were significantly cut.For the year ended January, the drug discovery

Read more
26 Feb 2019 16:08

UK Earnings, Trading Statements Calendar - Next 7 Days

Wednesday 27 February ITVFull Year ResultsRio TintoFull Year Results (at 0600 James's

Read more
10 Dec 2018 14:30

E-Therapeutics launches research collaboration with Novo Nordisk

(Sharecast News) - E-Therapeutics announced a research collaboration with Novo Nordisk on Monday, under which the two companies would use e-Therapeutics' proprietary 'Network-Driven Drug Discovery' (NDD) platform to look to discover potentially novel biological mechanisms and therapeutic approaches for a specific area of type-2 diabetes.

Read more
6 Dec 2018 16:04

E-Therapeutics and C4X upbeat on Parkinson's collaboration

(Sharecast News) - Network-driven drug discovery company e-Therapeutics and C4X Discovery Holdings updated the market on their collaboration on Thursday, to identify novel intervention strategies for the potential treatment of Parkinson's Disease (PD).

Read more
6 Dec 2018 09:23

e-Therapeutics And C4X Identify New Pathways For Parkinson's Treatment

LONDON (Alliance News) - C4X Discovery Holdings PLC and e-Therapeutics PLC on Thursday said that, through their collaboration, they discovered additional novel biological pathways for the of that

Read more
4 Oct 2018 11:08

e-Therapeutics narrows interim losses as it eyes commercial viability

(Sharecast News) - Half-year losses at e-Therapeutics have narrowed as the drug discovery and development firm continued to manage costs.

Read more
4 Oct 2018 10:31

e-Therapeutics Interim Loss Narrows As It "Carefully" Manages Costs

LONDON (Alliance News) - e-Therapeutics PLC said Thursday that its half-year loss narrowed as it continued to effectively and "carefully" manage its costs.For the six months ended

Read more
27 Sep 2018 16:16

UK Earnings, Trading Statements Calendar - Next 7 Days

Friday 28 September United UtilitiesTrading Statement Baillie Gifford Shin Year 1 events 2 3

Read more
24 May 2018 16:10

UK Shareholder Meetings Calendar - Next 7 Days

Friday 25 MayHochschild MiningFerrexpoKeywords Mutual (re managed 28 events 29 Stobart Life (re of

Read more
1 May 2018 11:41

e-Therapeutics Pens Research Collaboration With C4X Discovery

LONDON (Alliance News) - e-Therapeutics PLC and C4X Discovery Holdings PLC on Tuesday announced a research collaboration to look into insights into Parkinson's disease.The partnership,

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.